HIF2α, which is also increased in patients and mouse models of NASH, appears to influence liver inflammation via control of hepatocyte production of the cytokine histidine rich glycoprotein (HRGP) (3). This evidence concerns the gene EPAS1 and metabolic dysfunction-associated steatohepatitis.